Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
smaller droplets may reach the lungs Head position: Supine or reflex head extension during administration improves olfactory region deposition Volume control: Volumes exceeding 10 L per nostril in mice risk drainage into the trachea/lungs rather than CNS Systemic spillover: IN administration typically results in only 110% systemic bioavailability, so it is unsuitable when peripheral effects are the primary endpoint Practical Guidance for Route Selection Administration Schedule Considerations Dosing frequency should be matched to both the peptides half-life and the chosen route: Once-weekly peptides (semaglutide, tirzepatide, retatrutide, CJC-1295 DAC): SC only the slow-release profile requires subcutaneous deposition Daily peptides (BPC-157, GHK-Cu, TB-500): SC or IP, depending on whether local or systemic effects are desired Multiple daily peptides (ipamorelin, selank): SC or IN choose the least stressful route that achieves target bioavailability Short half-life CNS peptides (DSIP, Semax): IN preferred to avoid rapid systemic clearance Research Safety & Ethical Considerations Responsible peptide research requires rigorous attention to safety protocols, humane treatment of animal subjects, and experimental design that minimizes bias
Neither is necessarily "better" than the other
What are the negative effects of CJC-1295
Serotonin promotes mood, cognitive flexibility , and sociability (3-5) , and attenuates aggression and impulsivity (6)
The round lands roughly 13 months after the companys $70 million Series B and will fuel Nourishs clinical network, support its investment in AI agents and partnerships with health plans and employers
